Functional splicing assay supporting that c.70+5G>A mutation in the MPV17 gene is disease causing

3Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Mitochondrial DNA depletion syndrome (MDS) is a group of disorders characterized by a quantitative reduction of the mitochondrial DNA copy number and inherited as autosomal recessive traits. Patients affected by this group of diseases present with a wide variety of symptoms depending on the altered gene. MPV17 is one of the genes causing combined encephalopathy and liver failure and at present there is no treatment for this devastating disease. The gene codes for an inner mitochondrial membrane protein, but its function is still unknown, and therefore, the only way to offer prenatal diagnosis relies on DNA studies. Consequently, mutations have to be well characterized. We previously described a patient homozygous for a novel intronic mutation in the MPV17 gene (c.70+5G>A). Here we report the use of a functional splicing assay based on the use of minigenes to support that c.70+5G>A mutation is disease causing. We carried out three prenatal diagnoses on three consecutive pregnancies of the previously described family. After two affected fetuses, a healthy baby was born homozygous for the wild-type allele. © SSIEM and Springer 2010.

Cite

CITATION STYLE

APA

Navarro-Sastre, A., García-Silva, M. T., Martín-Hernández, E., Lluch, M., Briones, P., & Ribes, A. (2010). Functional splicing assay supporting that c.70+5G>A mutation in the MPV17 gene is disease causing. Journal of Inherited Metabolic Disease, 33(SUPPL. 3). https://doi.org/10.1007/s10545-010-9155-x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free